3320 J . Org. Chem., Vol. 64, No. 9, 1999
Halab and Lubell
(CDCl3) δ 21.4 (21.6), 23.4, 24.1 (24.3), (25.6) 26.0, 26.5 (29.0),
(27.3) 27.5, 28.1, 35.3 (35.9), 40.1 (41.9), 49.5 (51.1), (60.2) 61.4,
(66.9) 67.4, 79.6 (80.0), 155.3 (156.0), 172.8 (173.0), (174.5)
176.8; HRMS calcd for C20H37O5N2 (MH+) 385.2702, found
385.2710.
62.0, 67.4 (68.0), (169.8) 171.5, 171.7 (171.9), 175.4 (176.3);
HRMS calcd for C15H28O3N3 (MH+) 298.2131, found 298.2120.
N-Acetyl-(2S)-m eth ion yl-(2S,5R)-5-ter t-bu tylpr olin e N′-
m eth yla m id e (1c) was isolated in 99% yield as a white
solid: mp 53-56 °C; [R]20 -71.7° (c 0.4, CHCl3); 1H NMR
D
N-(BOC)-(2S)-p h e n yla la n yl-(2S,5R)-5-ter t-b u t ylp r o-
lin e (6f) was isolated in 64% yield as a white solid: mp 149-
(CDCl3) δ 0.85 (s, 6.6 H) [0.93 (s, 2.4 H)], 1.82 (m, 2 H), 1.96
(m, 4 H), 2.07 (s, 5 H), 2.53 (m, 3 H), [2.76 (d, 0.8 H, J ) 4.6)]
2.83 (d, 2.2 H, J ) 4.6), 4.23 (dd, 1 H, J ) 5.3, 8.2), 4.48 (m, 2
H), 7.72 (d, 1 H, J ) 6.2), 8.41 (br s, 1 H); 13C NMR (CDCl3) δ
(15.5) 15.6, 22.2 (22.5), 25.1 (25.5), (26.2) 26.3, 27.2, (27.4) 28.4,
30.3, 30.5, (35.1) 35.5, (49.7) 52.1, (61.6) 61.7, 67.4 (67.8),
(170.1) 171.0, (171.8) 172.2, 174.5 (175.2); HRMS calcd for
151 °C; [R]20 -66.7° (c 0.88, CHCl3); 1H NMR (CDCl3) δ 0.90
D
(s, 6.3 H) [1.03 (s, 2.7 H)], [1.29 (s, 2.7 H)] 1.39 (s, 6.3 H), 1.48
(m, 1 H), 1.76-1.96 (m, 3 H), 2.87 (m, 2 H), 3.75 (t, 1 H, J )
8.7), 4.06 (d, 1 H, J ) 8.5), 4.35 (d, 1 H, J ) 7.5), 5.60 (m, 1
H), 7.24 (m, 5 H); 13C NMR (CDCl3) δ 26.7 (28.0), 28.3, (28.6)
28.8, (28.5) 30.2, (36.7) 37.2, (38.7) 41.0, (54.2) 55.3, 62.8 (63.8),
68.0 (68.3), (80.4) 80.9, (127.5) 128.0, (129.3) 129.7, (130.5)
130.6, 138.0 (138.9), 157.1 (157.4), 174.5 (176.0), 179.5.
Gen er a l P r oced u r e for Am id a tion of th e Dip ep tid es.
A solution of N-(BOC)dipeptide 6 (104 mg, 0.26 mmol) in CH3-
CN (2.6 mL) was treated with DIEA (181 µL, 1.0 mmol),
methylamine hydrochloride (21 mg, 0.31 mmol), and TBTU
(100 mg, 0.31 mmol), stirred at room temperature for 18 h,
and partitioned between brine (2 mL) and EtOAc (10 mL). The
organic phase was washed with 0.1 M HCl (2 × 3 mL), 5%
NaHCO3 (2 × 3 mL), and brine (4 mL), dried, and evaporated
to yield the N-(BOC)dipeptide methylamide 7.
C
17H32O3N3 (MH+) 358.2131, found 358.2152.
N-Acet yl-(2S)-leu cyl-(2S,5R)-5-ter t-b u t ylp r olin e N′-
m eth yla m id e (1d ) was isolated in 98% yield as a white
1
solid: mp 172-173 °C; [R]20 -88.2° (c 0.3, CHCl3); H NMR
D
(CDCl3) δ 0.88 (s, 7.7 H) [0.91 (s, 1.3 H)], 0.92 (d, 3 H, J )
4.0), 0.97 (d, 3 H, J ) 6.6), 1.29 (m, 1 H), 1.58-1.72 (m, 3 H),
1.85 (m, 1 H), [1.98 (s, 0.4 H)] 2.04 (s, 2.6 H), 2.17 (m, 1 H),
2.48 (m, 1 H), [2.79 (d, 0.4 H, J ) 4.6)] 2.87 (d, 2.6 H, J ) 4.6),
4.29 (m, 3 H), 5.96 (d, 1 H, J ) 6.9), 8.26 (br s, 1 H); 13C NMR
(CDCl3) δ 21.2 (21.4), 22.4 (22.7), 23.3 (23.5), (24.4) 24.8, 25.2,
26.3 (26.4), 27.3 (27.6), 28.7, (35.0) 35.6, 39.5 (40.7), (48.6) 51.5,
(61.5) 61.8, 67.3 (67.9), 171.2, (171.8) 172.0, 174.8; HRMS calcd
for C18H34O3N3 (MH+) 340.2600, found 340.2611.
N-(BOC)-(2S)-leu cyl-(2S,5R)-5-ter t-b u t ylp r olin e
N′-
m eth yla m id e (7d ) was isolated in 97% yield as a white
N-Acet yl-(2S)-va lyl-(2S,5R)-5-ter t-b u t ylp r olin e
N′-
solid: mp 152-153 °C; [R]20 -95.9° (c 0.75, CHCl3); 1H NMR
m eth yla m id e (1e) was isolated in 97% yield as a white
D
1
(CDCl3) δ 0.87-0.94 (m, 15 H), 1.25 (m, 1 H), 1.42 (s, 9 H),
1.72-1.84 (m, 4 H), 2.17 (m, 1 H), 2.44 (m, 1 H), [2.78 (d, 0.5
H, J ) 4.7) 2.83 (d, 2.5 H, J ) 4.6), 4.12 (m, 1 H), 4.28 (m, 2
H), 4.92 (d, 1 H, J ) 7.7), 8.32 (br s, 1 H); 13C NMR (CDCl3) δ
21.3 (21.5), 23.4 (23.5), (24.3) 24.5, (24.8) 25.2, 26.1 (26.2), 27.2
(27.5), 28.0, 29.0 (29.6), (35.0) 35.7, 40.0 (41.0), (49.5) 51.9,
(61.5) 61.7, 67.0 (67.5), (79.8) 80.4, (155.1) 157.1, 171.5 (172.0),
175.2 (176.2); HRMS calcd for C21H40O4N3 (MH+) 398.3019,
found 398.3031.
solid: mp 166-167 °C; [R]20 -93.8° (c 0.3, CHCl3); H NMR
D
(CDCl3) δ 0.86 (s, 8 H), 0.97 (m, 4 H), 1.05 (d, 3 H, J ) 6.7),
1.81-2.06 (m, 7 H), 2.59 (m, 1 H), [2.80 (d, 0.3 H, J ) 4.6)]
2.84 (d, 2.7 H, J ) 4.6), 4.18 (t, 1 H, J ) 7.5), 4.30 (t, 1 H, J
) 7.3), 4.50 (m, 1 H), 6.18 (d, 1 H, J ) 6.2), 8.48 (br s, 1 H);
13C NMR (CDCl3) δ (18.0) 18.7, 19.3 (19.9), 22.6, (25.0) 25.2,
26.2 (26.5), 27.2, 27.9, 30.5, (35.0) 35.5, (55.6) 58.1, (61.3) 61.8,
67.0 (67.2), (169.2) 170.9, 171.5 (171.8), 174.3 (175.1); HRMS
calcd for C17H32O3N3 (MH+) 326.2444, found 326.2455.
N-(BOC)-(2S)-p h e n yla la n yl-(2S,5R)-5-ter t-b u t ylp r o-
lin e N′-m eth yla m id e (7f) was isolated in 49% yield as a
N-Acet yl-(2S)-p h en yla la n yl-(2S,5R)-5-ter t-b u t ylp r o-
lin e N′-m eth yla m id e (1f) was isolated in 94% yield as a
white solid: mp 81-82 °C; [R]20D -32.2° (c 1, CHCl3); 1H NMR
(CDCl3) δ 0.83 (s, 9 H), 1.16 (m, 1 H), 1.51-1.67 (m, 2 H), [1.90
(s, 0.3 H)] 2.00 (s, 2.7 H), 2.13 (m, 1 H), 2.79 (d, 3 H, J ) 4.6),
2.97-3.09 (m, 2 H), 3.71 (dd, 1 H, J ) 4.5, 8.9), 4.25 (dd, 1 H,
J ) 4.9, 8.7), 4.57 (m, 1 H), 6.72 (d, 1 H, J ) 5.6), 7.20-7.35
(m, 5 H), 8.37 (br s, 1 H); 13C NMR (CDCl3) δ 22.6 (22.7), 24.9
(25.1), 26.2 (26.4), 27.2 (27.5), 27.8, 35.5, 38.1 (38.4), 54.0, (61.5)
61.7, 67.3 (67.9), (127.0) 127.6, (128.4) 129.1, 129.2 (129.3),
white solid: mp 51-52 °C; [R]20 -28.6° (c 0.5, CHCl3); 1H
D
NMR (CDCl3) δ 0.82 (s, 9 H), 1.15 (m, 1 H), [1.36 (s, 1.4 H)]
1.43 (s, 7.6 H), 1.59 (m, 2 H), 2.08 (m, 1 H), 2.76 (d, 3 H, J )
4.6), 2.92 (m, 2 H), 3.57 (dd, 1 H, J ) 4.4, 8.9), 4.25 (dd, 1 H,
J ) 5.2, 8.6), 4.37 (m, 1 H), 5.12 (d, 1 H, J ) 7.0), 7.17-7.33
(m, 5 H), 8.38 (br s, 1 H); 13C NMR (CDCl3) δ 25.0, 25.9, 27.1,
27.9, 28.0, 35.6, 38.4, 54.5, 61.6, 66.9, 80.7, 127.5, 129.0, 129.3,
135.2, 156.2, 171.3, 174.6; HRMS calcd for C24H38O4N3 (MH+)
432.2862, found 432.2871.
Gen er a l P r oced u r e for Aceta m id e Syn th esis. A solution
of N-(BOC)dipeptide N′-methylamide 7 (62 mg, 0.16 mmol) in
1:3 TFA:CH2Cl2 (1.6 mL) was stirred at room temperature for
2 h and evaporated on a rotary evaporator. The resulting
dipeptide N′-methylamide trifluoroacetate was dissolved in
CH2Cl2 (1.6 mL), treated with K2CO3 (0.22 mg, 1.6 mmol) and
Ac2O (148 µL, 1.6 mmol), stirred for 18 h, filtered, washed with
CH2Cl2 (3 × 3 mL), and evaporated to give the N-acetyl-
dipeptide N′-methylamide 1.
134.5, 171.2, 173.9; HRMS calcd for
374.2444, found 374.2449.
C
21H32O3N3 (MH+)
N-Acet yl-(2S)-a la n ylp r olin e N′-m et h yla m id e a n d N-
a cetyl-(2S)-leu cylp r olin e N′-m eth yla m id e were synthe-
sized in solution phase from N-(BOC)-L-proline N′-methyla-
mide using the TBTU coupling and acetylation conditions as
described above.
N-Acetyl-(2S)-a la n ylp r olin e N′-m eth yla m id e (2a ): mp
176-177 °C; [R]20 -145.0° (c 0.5, CHCl3); 1H NMR (CDCl3) δ
D
[1.31 (d, 0.6 H, J ) 7.0)], 1.36 (d, 2.4 H, J ) 6.9), [1.78 (m, 0.2
H)] 1.92 (m, 0.8 H), 2.00 (s, 2.4 H) [2.01 (s, 0.6 H)], 2.03 (m, 1
H), [2.09 (m, 0.2 H)] 2.14 (m, 0.8 H), 2.34 (m, 0.8 H) [2.55 (m,
0.2 H)], 2.79 (d, 2.4 H, J ) 3.9) [2.85 (d, 0.7 H, J ) 3.8)], 3.57
(m, 1 H), 3.68 (m, 1 H), [4.31 (m, 0.2 H, J ) 8.2)] 4.53 (dd, 0.8
H, J ) 2.9, 8.1), [4.25 (m, 0.2 H)] 4.76 (m, 0.8 H), 6.53 (d, 0.8
H, J ) 6.3) [6.65 (br s, 0.2 H)], 6.72 (br s, 0.8 H) [7.58 (br s,
0.2 H)]; 13C NMR (CDCl3) δ (16.3) 17.8, (22.3) 22.8, (21.8) 24.8,
26.0 (26.4), 27.7 (31.3), 46.5 (48.0), (46.7) 47.2, 59.8 (60.7), 169.5
(170.9), (171.1) 171.5, (172.0) 172.4; HRMS calcd for C11H20O3N3
(MH+) 242.1505, found 242.1498.
N-Acet yl-glycyl-(2S,5R)-5-ter t-b u t ylp r olin e N′-m et h -
yla m id e (1a ) was isolated in 93% yield as a white solid: mp
71-73 °C; [R]20 -99.5° (c 0.46, CHCl3); mixture of 1:1
D
1
rotamers H NMR (CDCl3) δ 0.93 (s, 9 H), 1.27 (m, 1 H), 1.64
(m, 2 H), 1.85 (m, 1 H), 2.05 (s, 3 H), 2.82 (m, 3 H), 3.74 (d, 1
H, J ) 9.5), 4.20 (m, 2 H), 4.66 (m, 1 H), 6.43 (br s, 1 H), 7.14
(br s, 1 H); 13C NMR (CDCl3) δ 13.9, 22.5, 22.7, 25.0, 25.7, 26.2,
26.5, 27.4, 29.5, 30.2, 31.4, 35.6, 36.0, 42.2, 42.4, 61.7, 61.9,
67.4, 67.7, 170.2, 170.9, 171.1, 171.7, 171.9; HRMS calcd for
C
14H26O3N3 (MH+) 284.1974, found 284.1968.
N-Acet yl-(2S)-a la n yl-(2S,5R)-5-ter t-b u t ylp r olin e N′-
N-Acetyl-(2S)-leu cylp r olin e N′-m eth yla m id e (2b): mp
90-91 °C; [R]20D -130.3° (c 1, CHCl3); 1H NMR (CDCl3) δ 0.94
(m, 6 H), 1.53 (m, 1 H), 1.67 (m, 1 H), 1.88 (m, 3 H), 2.00 (s,
2.4 H) [2.02 (s, 0.6 H)], 2.15 (m, 1 H), 2.35 (m, 1 H), 2.77 (d,
2.4 H, J ) 4.8) [2.85 (d, 0.6 H, J ) 4.7)], 3.56 (m, 1 H), 3.76
(m, 1 H), 4.50 (dd, 1 H, J ) 2.7, 8.1), 4.81 (m, 1 H), 6.18 (d, 0.8
H, J ) 8.4) [6.29 (d, 0.2 H, J ) 6.1)], 6.72 (br s, 0.8 H) [7.52
(br s, 0.2 H)]; 13C NMR (CDCl3) δ (21.1) 21.6, (22.3) 22.8, 23.2
(23.3), 24.6 (24.7), (21.8) 24.8, 26.0 (26.5), 27.4 (31.2), 39.8
m eth yla m id e (1b) was isolated in 97% yield as a white
solid: mp 119-121 °C; [R]20 -60.3° (c 0.36, CHCl3); 1H NMR
D
(CDCl3) δ 0.89 (s, 7.5 H) [0.93 (s, 1.5 H)], 1.31 (d, 2.5 H, J )
6.9) [1.39 (d, 0.5 H, J ) 6.6)], 1.85 (m, 2 H), [1.97 (s, 0.5 H)]
2.01 (s, 2.5 H), 2.22 (m, 1 H), 2.45 (m, 1 H), [2.80 (d, 0.5 H, J
) 4.7)] 2.86 (d, 2.5 H, J ) 4.6), 4.32 (m, 3 H), 6.54 (d, 1 H, J
) 6.1), 8.35 (br s, 1 H); 13C NMR (CDCl3) δ (15.8) 16.0, 22.1
(22.6), (24.5) 25.2, 26.2 (26.4), 27.3 (27.5), 28.9, 35.6, 48.5, (61.6)